CARD15 status and familial predisposition for Crohn's disease and colonic gene expression

Claudio Csillag1, Ole Haagen Nielsen, Rehannah Borup

  • 1Department of Gastroenterology C, Herlev Hospital, University of Copenhagen, Herlev Ringvej, DK-2730, Herlev, Denmark. claudio@dadlnet.dk

Insights

Genetic mutations in Caspase Recruitment Domain 15 (CARD15) and family history do not correlate with colonic gene expression in Crohn's disease (CD) patients. This study found no significant gene expression differences based on CARD15 status or familial disposition for inflammatory bowel disease (IBD).

Area of Science:

  • Gastroenterology
  • Genetics
  • Molecular Biology

Background:

  • Familial disposition and Caspase Recruitment Domain 15 (CARD15) mutations are known risk factors for Crohn's disease (CD).
  • Understanding the genetic underpinnings of CD is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the correlation between CARD15 gene status, familial disposition for inflammatory bowel disease (IBD), and colonic gene expression profiles in CD patients.
  • To determine if DNA-microarray technology can identify distinct gene expression patterns associated with these risk factors.

Main Methods:

  • Colonoscopic tissue specimens from the descending colon of 45 CD patients were analyzed.
  • Gene expression profiling was performed using the Human Genome U133 Plus 2.0 GeneChip Array.
  • Patients were classified based on CARD15 mutation status and familial history of IBD; data were analyzed using dChip software.

Main Results:

  • No differentially expressed genes were found in CD patients with one or two CARD15 mutations compared to those with wild-type CARD15.
  • Only one differentially expressed expressed sequence tag (EST) was identified between patients with and without a familial disposition for IBD.
  • Hierarchical cluster analysis did not reveal distinct group homogeneity based on familial disposition.

Conclusions:

  • Gene expression profiling of mucosal biopsies from the descending colon in CD patients did not correlate with CARD15 status.
  • Colonic gene expression profiles could not be linked to familial disposition for IBD in this cohort.
  • Further research may be needed to identify other genetic or environmental factors influencing CD pathogenesis.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...